Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0001193125-25-314741

Director sold 14,000 shares at an average $13.50 ($189,000)

  • Director acquired 14,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wagner Heidi L · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-08 Exercise or conversion : show line 1 in the form 10b5-1 +7,000 $5.97 $41,790 51,930 D
2025-12-08 Sale : show line 2 in the form 10b5-1 −7,000 $13.00 $91,000 44,930 D
2025-12-08 Exercise or conversion : show line 3 in the form 10b5-1 +7,000 $5.97 $41,790 51,930 D
2025-12-08 Sale : show line 4 in the form 10b5-1 −7,000 $14.00 $98,000 44,930 D
Open-market sales · 14,000 sh · avg $13.50 · $189,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-08 Exercise or conversion : show line 5 in the form 10b5-1 Share Option (right to buy) −14,000 7,000 D
Loading xslF345X05/ownership.xml…